Literature DB >> 21511749

Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?

V M Patil1, F D Patel, S Chakraborty, A S Oinam, S C Sharma.   

Abstract

OBJECTIVE: Point doses, as defined by the International Commission on Radiation Units and Measurements (ICRU), are classically used to evaluate doses to the rectum and bladder in high dose rate intracavitary brachytherapy (HDR-ICBT) in cervical cancer. Several studies have shown good correlation between the ICRU point doses and the volumetric doses to these organs. In the present study we attempted to evaluate whether this correlation could be used to predict the volumetric doses to these organs.
METHODS: A total of 150 HDR-ICBT insertions performed between December 2006 and June 2008 were randomly divided into two groups. Group A (n=50) was used to derive the correlation between the point and volumetric doses using regression analysis. This was tested in Group B (n=100) insertions using studentised residuals and Bland-Altman plots.
RESULTS: Significant correlations were obtained for all volumetric doses and ICRU point doses for rectum and bladder in Group A insertions. The strongest correlation was found for the dose to 2 cc volumes (D(2cc)). The correlation coefficients for bladder and rectal D(2cc) versus the respective ICRU point doses were 0.82 and 0.77, respectively (p<0.001). Statistical validation of equations generated in Group B showed mean studentised residual values of 0.001 and 0.000 for the bladder and rectum. However, Bland-Altman analysis showed that the error range for these equations for bladder and rectum were ±64% and ±41% of the point A dose, respectively, which makes these equations unreliable for clinical use.
CONCLUSION: Volumetric imaging is essential to obtain proper information about volumetric doses.

Entities:  

Mesh:

Year:  2011        PMID: 21511749      PMCID: PMC3473656          DOI: 10.1259/bjr/33758793

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  30 in total

1.  Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.

Authors:  Natascha Wachter-Gerstner; Stefan Wachter; Evi Reinstadler; Claudia Fellner; Tomas H Knocke; Andre Wambersie; Richard Pötter
Journal:  Radiother Oncol       Date:  2003-09       Impact factor: 6.280

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.

Authors:  R G Dale
Journal:  Br J Radiol       Date:  1985-06       Impact factor: 3.039

4.  Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies.

Authors:  R M Lanciano; M Won; L R Coia; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-04       Impact factor: 7.038

5.  High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.

Authors:  R Ferrigno; P E dos Santos Novaes; A C Pellizzon; M A Maia; R C Fogarolli; A C Gentil; J V Salvajoli
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-08-01       Impact factor: 7.038

6.  The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.

Authors:  S W Chen; J A Liang; S N Yang; R T Liu; F J Lin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

7.  Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.

Authors:  Shang-Wen Chen; Ji-An Liang; Lian-Shung Yeh; Shih-Neng Yang; An-Cheng Shiau; Fang-Jen Lin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-10-01       Impact factor: 7.038

Review 8.  Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation.

Authors:  C G Orton; M Seyedsadr; A Somnay
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-11       Impact factor: 7.038

9.  Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society.

Authors:  Akila N Viswanathan; Beth A Erickson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

10.  Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.

Authors:  Jason Chia-Hsien Cheng; Lee-Cheng Peng; Yu-Hsuan Chen; David Y C Huang; Jian-Kuen Wu; James Jer-Min Jian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

View more
  2 in total

1.  The dosimetric impact of vaginal balloon-packing on intracavitary high-dose-rate brachytherapy for gynecological cancer.

Authors:  William M Rockey; Sudershan K Bhatia; Geraldine M Jacobson; Yusung Kim
Journal:  J Contemp Brachytherapy       Date:  2013-03-29

2.  Volumetric (3D) bladder dose parameters are more reproducible than point (2D) dose parameters in vaginal vault high-dose-rate brachytherapy.

Authors:  Lucas Gomes Sapienza; Adriana Flosi; Antonio Aiza; Antonio Cassio de Assis Pellizzon; Rubens Chojniak; Glauco Baiocchi
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.